AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 60 filers reported holding AURA BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $37,542,666 | 10.52% |
| Regency Capital Management Inc.\DE | 532,333 | $6,574,313 | 5.72% |
| Decheng Capital Management III (Cayman), LLC | 293,333 | $3,622,663 | 1.14% |
| Nantahala Capital Management | 803,325 | $9,921,064 | 0.96% |
| Matrix Capital Management Company, LP | 5,362,870 | $66,231,445 | 0.77% |
| Eventide Asset Management | 2,935,519 | $36,253,660 | 0.61% |
| Rock Springs Capital Management LP | 1,019,757 | $12,593,999 | 0.30% |
| Long Focus Capital Management, LLC | 180,175 | $2,225,161 | 0.10% |
| LEVIN CAPITAL STRATEGIES, L.P. | 70,000 | $864,500 | 0.10% |
| TBH Global Asset Management, LLC | 33,097 | $408,752 | 0.08% |